Literature DB >> 3741433

N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.

M Taton, P Benveniste, A Rahier.   

Abstract

N-[(1,5,9)-trimethyl-decyl)]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol 9 was designed to mimic the C9 or C8 high energy carbocationic intermediates postulated during the enzymic cyclization of 2,3-oxidosqualene to different triterpenes. The structurally new molecule 9 inhibits strongly cycloartenol and lanosterol cyclases in maize seedlings and rat liver microsomes respectively, whereas it does not inhibit beta-amyrin cyclase in the plant system. For the first time 2,3-oxidosqualene cycloartenol cyclase and beta-amyrin cyclase have been differentiated in the same plant material by use of a specific inhibitor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741433     DOI: 10.1016/s0006-291x(86)80562-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Sterol biosynthesis inhibitors: their current status and modes of action.

Authors:  E I Mercer
Journal:  Lipids       Date:  1991-08       Impact factor: 1.880

2.  2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.

Authors:  L Cattel; M Ceruti; G Balliano; F Viola; G Grosa; F Rocco; P Brusa
Journal:  Lipids       Date:  1995-03       Impact factor: 1.880

3.  Triterpenoid biosynthesis in tissue cultures of Glycyrrhiza glabra var. glandulifera.

Authors:  S Ayabe; H Takano; T Fujita; T Furuya; H Hirota; T Takahashi
Journal:  Plant Cell Rep       Date:  1990-08       Impact factor: 4.570

4.  Homology modeling and docking studies on oxidosqualene cyclases associated with primary and secondary metabolism of Centella asiatica.

Authors:  Vadlapudi Kumar; Chethan S Kumar; Gajula Hari; Nayana K Venugopal; Poornima D Vijendra; Giridhara Basappa B
Journal:  Springerplus       Date:  2013-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.